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Abstract
Metabolic Syndrome (MetS) is highly prevalent and has considerable public health impact, but its underlying genetic factors
remain elusive. To identify gene networks involved in MetS, we conducted whole-genome expression and genotype
profiling on abdominal (ABD) and gluteal (GLU) adipose tissue, and whole blood (WB), from 29 MetS cases and 44 controls.
Co-expression network analysis for each tissue independently identified nine, six, and zero MetS–associated modules of
coexpressed genes in ABD, GLU, and WB, respectively. Of 8,992 probesets expressed in ABD or GLU, 685 (7.6%) were
expressed in ABD and 51 (0.6%) in GLU only. Differential eigengene network analysis of 8,256 shared probesets detected 22
shared modules with high preservation across adipose depots (DABD-GLU=0.89), seven of which were associated with MetS
(FDR P,0.01). The strongest associated module, significantly enriched for immune response–related processes, contained
94/620 (15%) genes with inter-depot differences. In an independent cohort of 145/141 twins with ABD and WB longitudinal
expression data, median variability in ABD due to familiality was greater for MetS–associated versus un-associated modules
(ABD: 0.48 versus 0.18, P=0.08; GLU: 0.54 versus 0.20, P=7.8610
24). Cis-eQTL analysis of probesets associated with MetS
(FDR P,0.01) and/or inter-depot differences (FDR P,0.01) provided evidence for 32 eQTLs. Corresponding eSNPs were
tested for association with MetS–related phenotypes in two GWAS of .100,000 individuals; rs10282458, affecting
expression of RARRES2 (encoding chemerin), was associated with body mass index (BMI) (P=6.0610
24); and rs2395185,
affecting inter-depot differences of HLA-DRB1 expression, was associated with high-density lipoprotein (P=8.7610
24) and
BMI–adjusted waist-to-hip ratio (P=2.4610
24). Since many genes and their interactions influence complex traits such as
MetS, integrated analysis of genotypes and coexpression networks across multiple tissues relevant to clinical traits is an
efficient strategy to identify novel associations.
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Introduction
Genome-wide association (GWA) studies are routinely em-
ployed to identify common genetic variants contributing to
complex diseases. Many replicated GWA signals have been found
for metabolic traits including high-density lipoprotein (HDL), low-
density lipoprotein, body mass index (BMI), triglycerides (TG) and
blood pressure, greatly enhancing the understanding of the genetic
basis of these traits [1–6]. However, statistically significant signals
resulting from GWA studies do not necessarily lead directly to the
identification of genes associated with disease or provide limited
insights into the molecular mechanisms of the disease phenotype.
In addition, the associated SNPs explain a very small proportion of
the heritability estimated for the complex trait [7]. For example, a
GWA study for BMI in up to ,250,000 individuals identified 32
loci that, together, explain only 4.5% of the phenotypic variation
or ,6–11% of the genetic variation in BMI [3]. The 1000
Genomes Project Consortium tested ,95% of common variation
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only one-third of complex trait associations are likely to be caused
by common coding variation, indicating that most contributions of
common variation to complex traits are regulatory in nature [8].
eQTL (expression Quantitative Trait Loci) studies could help in
understanding how known genetic variants identified by GWA
studies influence clinical traits through gene expression, or suggest
potential biological pathways. eQTLs have already been associ-
ated to several complex traits including Type I diabetes [9],
asthma [10] and obesity [11]. In addition, eQTL studies have
shown that top hits from GWA studies are more likely to be
eQTLs [12,13] and eSNPs are enriched for association to Type 2
diabetes (T2D) [14]. Focusing on SNPs that have been associated
with an expression trait in the relevant tissue and testing whether
such eSNPs are associated with disease could highlight novel
genetic loci that fail to meet the stringent genome-wide
significance level of GWA studies.
Metabolic syndrome (MetS) is highly prevalent, occuring in up
to 22% of US individuals, and is a serious public-health problem
world wide [15]. Defined by The International Diabetes
Federation (IDF), it is characterized by central obesity plus the
presence of two of four heritable metabolic abnormalities: raised
TG; reduced HDL; hypertension; and hyperglycaemia. It is
considered a serious risk factor of both T2D and cardiovascular
disease [16]. Traditional approaches have highlighted insulin
resistance, obesity, inflammation, and glucose and/or lipid
metabolism to be important to the pathophysiology of the MetS
[17,18]. Body fat distribution plays an important role due to its
association with metabolic disorders. Individuals with increased
intra-abdominal/visceral fat (high waist-to-hip ratio (WHR)) are at
high risk of MetS, whereas those with increased subcutaneous fat
in the gluteofemoral region (low WHR) are at little or no risk of
MetS [19,20]. The adverse metabolic risk of visceral fat has been
attributed to distinct metabolic properties of adipocytes in this fat
depot compared with those in other sites, including differences in
metabolic responses, gene expression, adipokine secretion and
insulin action [21–23]. In addition, GWA studies have identified
multiple loci that modulate body fat distribution independent of
overall adiposity [24].
The estimated heritability of MetS ranges from 0.10 to 0.51,
whilst that of the individual traits that constitute MetS range from
0.13 to 0.72 [25–27]. The clinical clustering of individual MetS
traits may be explained by shared genetic and environmental
factors contributing to their origin [25]. GWA studies on the
individual metabolic traits have identified many genetic loci,
however, a much smaller number of genetic factors that influence
MetS as a clinical entity have been identified (www.genome.gov/
gwastudies, accessed 02-03-2011 [28]).
It is likely that for a clinical entity such as MetS comprising
multiple complex trait components, there is considerable genetic
heterogeneity in causal pathways. Therefore examining many
genes simultaneously using a systems-based approach, such as
weighted gene co-expression network analysis [29], may be more
powerful than analysing single-gene effects. A previous eQTL
study in adipose tissue has led to the identification of a
macrophage-enriched metabolic network which was enriched for
eQTL signals and associated with obesity-related traits [11].
However, the focus of most eQTL studies so far has been on single
tissue networks ignoring the fact that complex clinical entities such
as MetS are the result of interactions of multiple molecular
networks operating within and between tissues. In addition, it is
not often recognised that molecular phenotypes such as gene
expression traits are influenced by biological and technical
variation, affecting power of association detection.
To uncover eQTLs in tissues relevant to MetS, we analysed
gene expression profiles in abdominal (ABD) and gluteal (GLU)
adipose tissue, and whole blood (WB), from 73 individuals,
allowing the investigation of differential regulation between
different adipose depots applying both single-gene and a network
approaches. Using a second independent cohort comprising 145
and 141 twins with ABD and WB expression data collected
longitudinally across two visits, we demonstrate the relative
contribution of familial, environmental, and experimental vari-
ability to the MetS-associated expression phenotypes. Lastly, we
identify a set of SNPs associated with the expression of genes in
selected MetS-associated modules showing differential expression
between the adipose depots, and test these eSNPs for association
with MetS-related phenotypes in two large GWA cohorts.
Results
Single-gene associations between MetS and gene
expression
Figure S1 shows the study design. Using Affymetrix hgu133-
plus2 arrays, we analysed ABD, GLU and WB samples from 29
MetS cases and 44 controls from the MolOBB study. For each
subject, we collected six quantitative traits used to define MetS
including waist circumference, systolic and diastolic blood
pressure, TG, HDL and fasting glucose levels. We defined MetS
according to IDF Criteria [16]: central obesity, as assessed by waist
circumference plus any two of the following four components
(raised TG, reduced HDL cholesterol, raised blood pressure,
raised fasting plasma glucose) (Table 1). After filtering for high-
quality array data, we limited further analyses to 54, 65, and 68
individuals and those probesets that showed a mean intensity
above 4 arbitrary units of log2 (intensity) in at least 10% of
individuals resulting in 8941 (ABD), 8307 (GLU) and 6909 (WB)
gene expression profiles (probesets were mapped to Entrez Genes),
respectively (see Methods). We identified 893 and 335 genes
showing significant expression changes with MetS in ABD and
Author Summary
Metabolic Syndrome (MetS) is a highly prevalent disorder
with considerable public health concern, but its underlying
genetic factors remain elusive. Given that most cellular
components exert their functions through interactions with
other cellular components, even the largest of genome-
wide association (GWA) studies may often not detect their
effects, nor necessarily provide insight into the complex
molecular mechanisms of the disease. Rather than focusing
on individual genes, the analysis of coexpression networks
can be used for finding clusters (modules) of correlated
expression levels across samples. In this study, we used a
gene network–based approach for integrating clinical MetS,
genotypic, and gene expression data from abdominal and
gluteal adipose tissue and whole blood. We identified
modules of genes related to MetS significantly enriched for
immune response and oxidative phosphorylation pathways.
We tested SNPs for association with MetS–associated
expression (eSNPs), and tested prioritised eSNPs for
association with MetS–related phenotypes in two large-
scale GWA datasets. We identified two loci, neither of which
had reached genome-wide significance levels in GWAs,
associated with expression levels of RARRES2 and HLA-DRB1
and with MetS–related phenotypes, demonstrating that the
integrated analysis of genotype and expression data from
relevantmultipletissuescanidentifynovelassociationswith
complex traits such as MetS.
Adipose eSNPs Associated with Metabolic Syndrome
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with 210 genes overlapping (‘single-gene analysis’) (Figure 1, Table
S1, Table S2). Hierarchical clustering of the differentially
expressed genes showed distinct clustering of the majority of
MetS cases. Clustering was independent of gender or the presence
of specific subsets of the two MetS components as defined in the
IDF criteria (waist circumference plus any two of the four MetS
components) (Figure 1).
The large overlap between the two fat depots supports the
robustness of the data and consistency across fat depots. Among
the top 10 genes that were associated with MetS was KCTD10;
SNPs at this locus were previously associated with HDL [31]
(Figure 1C). To validate these findings further, we compared
previously implicated MetS-associated loci [32] and obesity-
related gene expression differences [11] with the MetS-associated
expression differences in our study. This comparison revealed
consistency for MetS-associated expression differences including
LPL, C3AR1, HSD11B1, and FAT3 in ABD and APOE, FAT3 and
FNDC4 in GLU (Table S3, Table S4).
None of the genes was differentially expressed between MetS
cases and controls in WB although for the individual MetS
components (122 genes for waist circumference, nine genes for TG
and one gene for HDL) significant gene expression differences
were identified (not shown). Only two of these genes, ATP5E and
BLVRB showed significant expression changes with multiple MetS
components (waist circumference (FDR P=9.0 *10
23) and TG
(FDR P=0.01); waist (FDR P=5.7 *10
23) and HDL (FDR
P=4.3 *10
23) indicating that MetS gene expression differences
were more pronounced in the fat depots, which became the main
focus of further analysis.
The distribution of adipose tissue between ABD and GLU
depots varies between individuals and this variation is associated
with MetS and some of the WHR-associated loci have shown
depot-specific differences in expression patterns and/or an
enrichment of associations with metabolic phenotypes [24]. This
led us to test the hypothesis that MetS-associated expression
differences found for genes expressed in both depots might reflect
depot-specific expression differences. Whereas 8.9% and 13% of
the genes associated with MetS in ABD or GLU only exhibited
depot-specific differential expression, 44 of the 210 overlapping
MetS-associated genes (21%) including KCTD10 and C3AR1
showed evidence for depot-specific expression changes. These
findings support the hypothesis that, at least for some genes, the
associations with MetS reflect depot-specific differences.
Construction of weighted coexpression networks
A Pearson correlation matrix (containing an estimate of each
pairwise correlation between gene expression levels, irrespective of
MetS status) was calculated and transformed into a matrix of
connection strengths using a power function resulting in a
weighted network (see Methods and [33]). Using these connection
strengths, genes were clustered in distinct groups of highly
connected genes (modules). For each gene in a module, we
calculated the Module Membership (MM) by correlating its gene
expression profile with the module eigengene (the first principal
component of the gene expression profiles in each module). Genes
with high MM values to the respective module are considered
hubgenes (see Methods and [30]).We constructed gene networks
separately for each of the three MolOBB tissue datasets and
identified 20, 26 and 18 modules in ABD, GLU and WB,
respectively. To distinguish between modules, each module was
assigned an arbitrary color. Figure S2 depicts a hierarchically
clustered connectivity matrix of the ABD dataset and the 20
identified modules.
Biological significance of network modules
We examined the biological significance of the identified
modules by testing for 1) association with MetS 2) enrichment of
Gene Ontology (GO) terms 3) hubgenes and 4) previous
implicated genes. For the former, we extracted the first principal
component of the gene expression profiles in each module (module
‘eigengene’) and tested its association with MetS (see Methods).
From the 20, 26 and 18 modules found in ABD, GLU and WB,
nine, six and zero modules, respectively, were associated with
MetS (FDR P,0.01, Table 2). Four of the nine ABD MetS-
Table 1. Characteristics of the participants included in ABD gene expression analyses (with both nonmissing expression and
phenotype data).
Sample characteristics All cases All controls Male cases Female cases Male controls Female controls
Sample size (N) 22 32 13 9 20 12
Age (years) 48654 9 654 7 644 9 664 9 654 9 65
Waist (cm) 107614 90611 108613 105616 93610 87612
HDL (mmol/l) 0.9960.25 1.4160.33 0.8860.15 1.1560.27 1.2960.33 1.6360.19
TG (mmol/l) 2.161.3 1.160.3 2.561.5 1.760.9 1.060.3 1.160.4
Diastbp (mm Hg) 90611 77668 9 612 91611 76657 9 66
Systbp (mm Hg) 134616 120611 132616 136617 120671 2 2 615
Glucose (mmol/l) 5.960.8 5.160.3 5.760.6 6.161.0 5.160.3 5.060.3
Reduced HDL (N)
* 20 5 12 8 5 0
Raised TG (N) 15 1 10 5 0 1
Raised Blood Pressure (N)
* 1 4 67733
Raised Glucose (N) 14 1 7 7 1 0
T2D (N)
* 101000
Values are means 6 standard deviation for each quantitative variable.
*Individuals (N=7) with treatment for lipid abnormalities or hypertension were assigned as having reduced HDL or raised blood pressure. T2D is defined as fasting
blood glucose .7.0 mmol/l or antiglycemic treatment).
doi:10.1371/journal.pgen.1002505.t001
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modules showed a significant (FDR P,0.01) enrichment of GO
terms (Table 3). In the ABD brown module, the eigengene was
downregulated for MetS cases compared to MetS controls
indicating that genes positively correlated with the eigengene
(MM.0) were downregulated in MetS cases. This module was
enriched for GO Biological Processes related to oxidative
phosphorylation pathways (GO: 0006082 organic acid metabolic
process (FDR P=7.9*10
27) and GO:0006091 generation of
precursor metabolites and energy (FDR P=7.5*10
27). For these
GO categories, the majority of the genes (more than 84% of genes
with MM.0) were downregulated in MetS cases. The genes in
these GO categories had a higher median MM (MM.0.74) than
the 877 genes in the module (MM=0.51) showing functional
relevance of these genes in the module. Furthermore, among the
top 10 genes with the highest rank of membership (hubgenes),
eight were previously implicated in mitochondrial processes
including generation of metabolites and energy (ATP5B, ACO2,
SUCLG1 and UQCRC), oxidation reduction (MOSC1, MOSC2,
LDHD) and fatty acid oxidation (ECHS1) (Table S5, Figure 2A).
This module contained the genes LPL, FAT3 and PPMG1 for
which SNPs were previously associated with MetS (Table S4) [32].
The eigengene of the ABD cyan module was upregulated for
MetS cases compared to MetS controls and genes in this module
were enriched for immune response related GO categories.
CD163, C1QB, C1QC and C3AR1, which are involved in the
inflammatory response and/or complement cascade were among
the strongest hubgenes (Table S5). This module contained three of
Figure 1. Gene expression changes related to MetS in ABD and GLU. A,B. Heatmap of scaled expression values of 893 and 335 differentially
expressed genes between MetS cases and controls in ABD (A) and GLU (B) samples. The dendogram depicts hierarchical clustering of the differentially
expressed genes. The bottom bars show black boxes for MetS, the presence of the MetS components (reduced HDL, raised TG, raised fasting glucose,
raised blood pressure) and gender (females). C. The top 10 genes differentially expressed in ABD and the top 10 genes differentially expressed in GLU.
The horizontal bars displays 2log10 Pvalues for differential expression between MetS cases and controls in ABD and GLU and between depots.
doi:10.1371/journal.pgen.1002505.g001
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significant MM (MM.0.75) from a previously identified macro-
phage-enriched metabolic network in subcutaneous adipose tissue
in humans and mice that was associated with obesity-related traits
and enriched for inflammatory response and macrophage
activation pathway [11] (Table S3). In addition, CD163 encodes
a monocyte/macrophage specific receptor whose soluble form
(sCD163) is elevated in T2D and obesity [34]. Although, gene
identity and connectivity strength of the previously published
module was not available, which is required for a comprehensive
comparison between studies, the modules might represent similar
immune-response related processes in ABD.
For the GLU samples, the brown module showed an
enrichment for glucose metabolic processes (GO:0045913 positive
regulation of carbohydrate metabolic process (FDR
P=3.8*10
23)). For the darkgreen GLU module eigengene, the
strongest MetS-associated module in GLU and associated with all
MetS components (FDR P,0.01), an upregulation among MetS
cases was observed as compared to controls. No significant
enrichment of GO terms was observed among the genes in the
module (Table 3). Among the top 10 of hubgenes in the darkgreen
GLU module, were GLUL (MM=20.89) and PHLDA2
(MM=0.84) (Table S5, Figure 2B). Both these genes are highly
differentially expressed between depots (FDR P,0.01). GLUL,
encoding glutamate synthase, showed lower expression levels in
GLU, as compared to ABD but the relation of this gene to MetS is
unknown. PHLDA2 encoding pleckstrin homology-like domain,
family A, member 2 was upregulated in GLU as compared to
ABD and is known to be involved in fetal growth with elevated
placental expression associated with low birth weight [35].
Differences in single-gene and single-tissue network
approaches
To investigate to what extent gene expression probesets
identified in the single-gene analyses as associated with MetS
were included in the MetS-associated modules, and signified
hubgenes, the correlation between MM and gene significance
(direct association between gene expression probeset and MetS
from single-gene analyses) was calculated for each gene expression
probeset (see Methods and [33]). For 862/893 (97%) and 238/335
(71%) of the MetS-associated probesets in ABD (p,0.01,
MM.0.36) and GLU (p,0.01, MM.0.41), a significant
association with a MetS-associated module eigengene was found
(147 probesets were overlapping). For the ABD brown (Pearson
r.0.41, p,10
236) and the GLU darkgreen modules (Pearson
r.0.57, p,10
29) most significantly associated with MetS
(Table 2), the correlations between gene significance for MetS
and the individual MetS components and MM were highly
significant (Figure 3, Figure S3). These results imply substantial
concordance in results between the two approaches and support
the increased power of the network-based approach by reducing
the number of tests significantly. A further advantage of the
network approach is the identification of distinct functional
modules within single-tissue networks that associated with MetS.
Genes that fall into these modules were more highly connected
than with genes in other modules (Figure S2) and their relevance
can be inferred based on the correlation with the eigengene. The
MetS-associated modules were enriched for immune response and
oxidative phosphorylation pathways consistent with studies
showing that adipose tissue secretes factors that regulate energy
homeostasis and the immune response and the activation of
inflammatory signalling pathways that emerges in the presence of
obesity, insulin resistance and T2D [11,36].
Differential eigengene network and GO analysis of ABD
and GLU expression data
MetS is a complex trait that is manifested in multiple tissues
and where regulatory processes may act specific to a tissue as
well as across tissues. The regulatory processes that play a role
within a tissue may differ from those processes across tissues. It is
Table 2. Modules for which eigengenes were significantly correlated (FDR p,0.01) with MetS in ABD (N=9) and GLU (N=6).
Depot module N genes N DE genes* MetS Waist HDL TG Diast bp** Syst bp*** Glucose
ABD brown 877 69 (8%) 2.5E-05 1.5E-06 1.0E-07 6.5E-03 5.2E-03 0.08 0.19
ABD cyan 582 63 (11%) 4.0E-05 2.2E-09 6.1E-09 3.6E-04 4.0E-04 0.02 0.02
ABD black 1065 142 (13%) 7.1E-05 2.2E-09 1.4E-04 6.5E-03 5.5E-05 4.2E-04 0.02
ABD pink 331 13 (4%) 1.4E-04 9.7E-03 2.9E-03 0.43 0.02 0.13 0.19
ABD darkred 133 22 (17%) 7.7E-04 4.0E-03 1.1E-04 4.2E-03 0.04 0.26 0.19
ABD blue 1231 57 (5%) 9.8E-04 4.5E-06 7.2E-06 0.19 9.7E-03 0.12 0.19
ABD darkgrey 290 63 (22%) 1.7E-03 1.2E-09 1.7E-04 3.6E-04 2.7E-04 9.4E-05 0.02
ABD royalblue 156 9 (6%) 5.0E-03 0.28 0.01 0.71 0.50 0.96 0.90
ABD purple 248 32 (13%) 5.5E-03 8.1E-04 0.07 0.30 1.5E-03 0.02 0.03
GLU darkgreen 107 28 (26%) 1.4E-08 2.2E-13 3.7E-07 5.1E-06 3.9E-07 2.5E-06 2.1E-04
GLU darkred 411 68 (17%) 2.7E-05 2.7E-08 3.7E-07 5.1E-06 2.4E-04 2.7E-04 0.03
GLU royalblue 141 27 (19%) 2.7E-05 8.6E-09 1.7E-05 2.3e-04 2.4E-04 1.6E-04 0.04
GLU black 338 17 (5%) 2.3E-03 9.9E-05 1.7E-04 0.02 1.7E-03 5.8E-03 0.21
GLU brown 771 72 (9%) 2.9E-03 2.3E-06 2.1E-05 1.2E-03 5.8E-03 3.5E-03 0.23
GLU cyan 211 59 (28%) 5.4E-03 5.1E-05 0.08 0.13 5.8E-03 0.02 0.04
FDR corrected pvalues for the associations with MetS and six quantitative metabolic traits are shown.
*DE=differentially expressed between adipose depots;
**Diast bp=diastolic blood pressure;
***Syst bp=systolic blood pressure.
doi:10.1371/journal.pgen.1002505.t002
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tissues, these modules may highlight communication between
tissues and elucidate biological pathways that are shared among
the tissues. Studying differential expression of individual genes in
the module may reveal differences in pathway regulation across
tissues.
To examine to what extent biological processes underlying
MetS are shared and differentially regulated among the different
adipose depots, we first examined the overlap of expressed genes
between ABD and GLU (Figure S4). Of 8992 probesets expressed
in ABD or GLU, 685 (7.6%) were expressed in ABD; 51 (0.6%) in
GLU and 8256 (92%) in both adipose depots. For 679 of the 8256
probesets (8.2%), differential expression between depots was found
(FDR P,0.01). GO analysis of the 685 ABD-only probesets
showed enrichment for common GO terms (GO:0051171,regu-
lation of nitrogen compound metabolic process (FDR
P=7.5*10
23)) and other gene transcription terms whilst analysis
of the 51 GLU-only probesets showed no enrichment. The
enrichment of gene transcription categories among genes ex-
pressed in ABD only might suggest regulatory processes specific for
ABD rather than genes that are able to induce gene activity
changes in other tissues. The large overlap of expressed genes
among ABD and GLU, however, suggest the existence of shared
processes or at least communication between tissues.
To examine whether the eigengene networks are similar across
fat depots, we calculated spearman correlations for the median
expression (r=0.98, p,1*10
210 and whole-network connectivi-
ties (r=0.66, p,1*10
210) between ABD and GLU (Figure S5).
These significant correlations suggest that the ABD and GLU
networks are comparable.
Next, we applied differential eigengene network analysis on
8256 genes that were expressed in both the ABD and GLU
datasets [29]. In this analysis, we detected 22 consensus modules,
i.e., modules that are shared by the ABD and GLU datasets. To
identify differences in pathway regulation between ABD and GLU
depots, we examined the relationship between all pairs of the
consensus module eigengenes represented by consensus networks
(see Methods and [29]). For each individual eigengene within an
adipose depot, we found that its relationship with the other
eigengenes was highly preserved across the adipose depots, with an
Table 3. Biological Processes GO terms were significantly enriched (FDR P,0.01) in 15 modules associated with MetS in ABD and
GLU.
Depot Module Term Count % P value
* FE
** FDR P
ABD brown GO:0006091,generation of precursor metabolites and energy 52 5.9 1.1E-09 2.5 7.5E-07
ABD brown GO:0006082,organic acid metabolic process 69 7.9 2.3E-09 2.1 7.9E-07
ABD brown GO:0042180,cellular ketone metabolic process 68 7.8 1.4E-08 2.0 3.1E-06
ABD brown GO:0022900,electron transport chain 26 3.0 3.2E-07 3.1 5.4E-05
ABD brown GO:0051186,cofactor metabolic process 31 3.5 1.7E-05 2.3 2.3E-03
ABD cyan GO:0009611,response to wounding 48 8.2 3.9E-10 2.7 2.5E-07
ABD cyan GO:0006959,humoral immune response 15 2.6 7.8E-08 5.8 2.5E-05
ABD cyan GO:0006952,defense response 45 7.7 7.9E-08 2.4 1.7E-05
ABD cyan GO:0006956,complement activation 10 1.7 1.9E-06 7.6 3.1E-04
ABD cyan GO:0048731,system development 99 17.0 7.0E-05 1.4 9.0E-03
ABD black GO:0009889,regulation of biosynthetic process 232 21.8 3.7E-06 1.3 2.6E-03
ABD black GO:0060255,regulation of macromolecule metabolic process 257 24.1 8.5E-06 1.3 3.0E-03
ABD black GO:0080090,regulation of primary metabolic process 255 23.9 1.9E-05 1.2 4.5E-03
ABD black GO:0051171,regulation of nitrogen compound metabolic process 217 20.4 2.1E-05 1.3 3.7E-03
ABD blue GO:0002504,antigen processing and presentation of peptide or polysaccharide
antigen via MHC class II
10 0.8 6.0E-07 6.7 4.5E-04
GLU darkred GO:0009611,response to wounding 41 10.0 1.2E-11 3.3 6.7E-09
GLU darkred GO:0006952,defense response 38 9.3 2.6E-09 3.0 7.4E-07
GLU darkred GO:0009653,anatomical structure morphogenesis 51 12.4 1.3E-06 2.0 2.5E-04
GLU darkred GO:0006956,complement activation 9 2.2 2.3E-06 9.1 3.3E-04
GLU darkred GO:0009887,organ morphogenesis 29 7.1 6.2E-06 2.6 7.0E-04
GLU darkred GO:0006959,humoral immune response 11 2.7 7.4E-06 6.0 7.0E-04
GLU darkred GO:0048731,system development 75 18.3 1.7E-05 1.6 1.4E-03
GLU darkred GO:0030198,extracellular matrix organization 13 3.2 1.8E-05 4.6 1.3E-03
GLU darkred GO:0048513,organ development 61 14.9 2.0E-05 1.7 1.3E-03
GLU darkred GO:0002252,immune effector process 14 3.4 5.9E-05 3.8 3.4E-03
GLU darkred GO:0050778,positive regulation of immune response 13 3.2 9.5E-05 3.9 4.9E-03
GLU darkred GO:0048583,regulation of response to stimulus 25 6.1 1.0E-04 2.4 4.9E-03
GLU brown GO:0045913,positive regulation of carbohydrate metabolic process 9 1.2 5.8E-06 7.2 3.8E-03
*P value=Fisher Exact Test;
**FE=Fold Enrichment.
doi:10.1371/journal.pgen.1002505.t003
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ABD,GLU) of 0.89
(see Methods; Figure S6).
To assess the relevance of the consensus modules for MetS, we
tested the consensus module eigengenes for association with MetS
(Table S6). Eigengenes of seven consensus modules (six in ABD and
six in GLU) were associated with MetS of which five modules were
overlapping (FDR P,0.01) (Table S6), suggesting that, in general,
the effect of consensus modules on MetS was not characterized by
different patterns of coexpressed genes between different adipose
depots. The yellow module eigengene showed the strongest
association with MetS in both the ABD (FDR P=1.4*10
25)a n d
the GLU dataset (FDR P=4.6*10
26) and was upregulated in MetS
cases as compared to controls in both fat depots. The genes in this
yellow module were enriched for immune response related
processes (Table S7). Among the hubgenes of the yellow module,
that is, the genes with the highest rank of module membership in
both networks, were C3AR1, CD163 and c22orf9 and NPC2
(Figure 2C and 2D and Table S8). Consistent with the overlap of
hubgenes between the cyan ABD module and the consensus
module, the module eigengenes of ABD cyan and the yellow
consensus module were highly correlated (r=0.97, p,1*10
210)
and contained many common genes (310 genes).
The yellow module eigengenes in ABD and GLU were highly
correlated (r=0.81) and not differentially expressed (p=0.64).
However, 94 genes of the 620 genes (15%) were differentially
expressed between depots (FDR P,0.01) which were enriched for
the GO-term: GO:0009611 response to wounding (FDR
P=2.3*10
23) (see Methods). Among these differentially expressed
genes, were the hubgenes C3AR1, C1QC, CD163 involved in the
complement cascade suggesting that the inflammatory response
overlapping in the fat depots are regulated through common
genes.. Thus, the results suggested the presence of a specific, highly
Figure 2. MetS-associated modules found in the different fat depots. Visualization of the ABD brown (A), GLU darkgreen (B), consensus
yellow in ABD (C) and consensus yellow in GLU (D) modules, respectively. For each module the top 150 pairwise correlations (intramodular
connectivities) are shown. Genes with the top 10 highest ranked module membership are displayed in larger circles.
doi:10.1371/journal.pgen.1002505.g002
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pathways containing a significant number of inter-depot differen-
tially expressed genes which may indicate differential regulation
between adipose depots.
Variability of MetS-associated gene expression from
single-gene analyses
Variation of gene expression traits may be driven by biological
as well as experimental factors. Characterizing and quantifying
sources of variation of gene expression traits or module eigengenes
is important for the identification of regulatory genetic variants. In
a separate dataset (MolTWIN) of 154 healthy twins, we retained
gene expression of 202 ABD and 191 WB samples from 145 and
141 twins after quality control, respectively (202/191 visits, with
29/26 duplicate measurements (see Methods)). To examine
whether the two independent ABD datasets were comparable,
spearman correlations for the median expression (r=0.96,
p,1*10
210), whole-network connectivities (r=0.51, p,1*10
210)
and the intramodular connectivities for the brown module
(r=0.71, p,1*10
210) were calculated using the module assign-
Figure 3. Scatterplot between MM (x-axis) and gene significance (y-axis) for MetS and the six MetS components in the ABD brown
module. Gene significance was defined as 2log10 pvalue of the probeset-clinical trait association for each gene in the brown module. Gene
expression probesets marked in red showed evidence for a cis eQTL, and their eSNPs were examined for association with BMI, HDL and TG (Table 4).
doi:10.1371/journal.pgen.1002505.g003
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The significant correlations suggested that the ABD networks were
comparable.
The MolTWIN dataset allowed us to decompose the biological
and experimental variation underlying an expression trait into five
components: familiality (genetic and common environment effects
shared by twin pairs); individual environment (unique for twin
individual); common visit and individual visit effects, which
respectively measure the amount of shared (by twins within a
pair) and non-shared variation occurring in the phenotype over
the sampling period. The residual component of variation
comprised experimental effects (two technical replicates of the
same sample). Familiality and individual environment variation
assess longitudinally stable, and common and individual visit
variation, short-term biological components. Although, our main
focus –given the size of the MolTWIN datasets– was on estimating
familiality, we also included heritablity estimates for contrast and
completeness (Table S9). We assessed the relative proportions of
the five sources of variances using a twin mixed-effects modelling
approach (see Methods) retaining 6787 probesets expressed in
MolTWIN ABD and WB, and for four groups of probesets
selected for association with MetS in MolOBB identified in single-
gene analysis and expressed in MolTWIN and in MolOBB 1) 626/
893 ABD probesets; 2) 205/335 GLU probesets; 3) 121/210
probesets with expression in both tissues and 4) 22/121
differentially expressed probesets (see Methods).
Familiality was the largest source of variation that contributed
to the variance of the gene expression traits in ABD and WB
(Figure 4, Text S2). The four groups of MetS-associated probesets
showed similar familiality patterns, and their median familiality
estimates were significantly higher compared to the probesets not
associated with MetS, in both MolTWIN ABD and in WB (Table
S9). Also, the groups of MetS-associated probesets showed a
greater median familiality in ABD than in WB (Table S9). The
highest median estimates were found for the 121 probesets
associated with MetS in ABD+GLU (0.43, IQR: 0.18), and the 22
associated with MetS and differentially expressed between ABD
and GLU (0.41, IQR: 0.15; Table S9). In addition to familiality,
we estimated heritabilities for the groups of MetS-associated
probesets, and the heritability patterns were similar as the
familiality patterns in ABD but not in WB which might suggest
an enrichment of genetic signals in ABD but not in WB.
Variance decomposition of module eigengenes
We also used the MolTWIN data to characterize the sources of
variation underlying the eigengenes of the MetS-associated
modules from the MolOBB data. Rather than constructing
networks in MolOBB and MolTWIN separately, we calculated
module eigengenes in the MolTWIN study using the module
assignments from MolOBB and decomposed the module eigen-
genes into the five variance sources as described above (Figure 5,
Text S2). The variability patterns of the eigengenes were
consistent with the results for probesets identified using the
single-gene approach. Median familiality estimates from MolT-
WIN ABD (Figure 5A) were greater for MetS-associated module
eigengenes than those not associated with MetS in MolOBB ABD
(median=0.48, IQR=0.30 vs median=0.18, IQR=0.28,
p=0.08) and GLU (median=0.54, IQR=0.10 vs median 0.20,
IQR=0.28, p=7.8*10
24). This pattern was not observed for
familiality estimates derived from MolTWIN WB (Figure 5B). For
the MetS-associated modules, median heritability estimates were
significantly greater than for modules not associated with MetS in
ABD (median=0.41, IQR=0.27 vs median=6.9*10
25,
IQR=0.25, p=0.03) and GLU (median=0.65, IQR=0.32 vs
median=0.14, IQR=0.28, p=0.007).
eQTL Analysis of differentially expressed genes
To assess whether specific genetic loci were associated with
MetS-associated gene expression in ABD and GLU, we performed
cis eQTL analyses (cis defined as SNP location within 500 kb of the
gene start or stop position; eQTLs are defined as genomic loci that
regulate expression levels of mRNAs or proteins). For the ABD
eQTL analysis, we used both ABD datasets (MolOBB and
MolTWIN) comprising 189 individuals whilst for the GLU dataset
we used 62 individuals from the MolOBB dataset. Out of the 8242
ABD genes tested, we found 1287 cis eQTL genes (FDR P,0.01)
using a fixed-effects meta-analysis [37]. We found evidence for an
eQTL in cis for 77 of the 893 probesets associated with MetS in
the single-gene meta-analysis. Six of these eQTL genes showed
significant inter-depot differences (Table 4). For the GLU eQTL
Figure 4. Sources of gene expression variation in different tissues. A) 626 probesets associated with MetS in MolOBB ABD B) 205 probesets
associated with MetS in MolOBB GLU. Variances are decomposed in MolTWIN ABD and WB.
doi:10.1371/journal.pgen.1002505.g004
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(empirical p,0.01, see Methods). We found a cis eQTL for 6/335
genes associated with MetS. Two of these genes ATP8B4 and
LTBP2, exhibited differential expression between ABD and GLU
(Table 4). Only one of these MetS eSNPs (an eSNP has been
defined as a SNP associated with an expression trait), rs8207,
affecting PHOSPHO2 expression levels, was found in both ABD
and GLU analyses but none of the corresponding expression
probesets showed significant differences between adipose depots
(Table 4).
We similarly calculated cis eQTL associations for probesets in
the ABD brown and GLU darkgreen modules most significantly
associated with MetS in MolOBB. For 124/877 genes in the ABD
brown module (877 tests), we found evidence for an eQTL in cis.
For 14/124 genes, a high MM (p,0.01) and a significant
association with MetS was found (Table 4; Figure 3). For the
GLU darkgreen module comprising 107 genes, we found two
eQTL genes that were significantly associated with MetS and high
MM (p,0.01) (Table 4; Figure S3). For the yellow consensus
module (620 genes), shared between ABD and GLU datasets, we
found 69 and 26 genes with evidence for an eQTL in cis in ABD
and GLU respectively; five eQTLs in ABD and four eQTLs in
GLU, had corresponding genes exhibiting interdepot expression
differences (Table 4).
To validate the eQTL analysis, we evaluated 29 SNPs and their
proxies (r
2.0.5) that were associated with MetS in a GWA of
22,161 participants [32]. In both ABD and GLU, an eQTL for
HERPUD1 (rs3764261) was found (Table S4).
Modules are groups of highly correlated genes and could be the
result of transcriptional co-regulation. We examined whether we
could find genomic hotspots i.e. genetic loci that regulate multiple
genes that are coexpressed within the module. We tested the
module eigengenes of the ABD brown, GLU darkgreen and yellow
consensus modules for association with 296,017 SNPs. After
Figure 5. Sources of variation for module eigengenes. Median estimates from: A) MolTWIN ABD and B) MolTWIN WB. From left to right:
eigengenes in MolTWIN are calculated from MolOBB ABD, GLU and WB probesets. In each plot, eigengenes are ordered by decreasing association
with MetS from left to right (modules significantly associated with MetS are marked with * above the bar). Red is familiality, green is individual
environment, cyan is individual visit, blue is common visit and grey displays residual variance.
doi:10.1371/journal.pgen.1002505.g005
Adipose eSNPs Associated with Metabolic Syndrome
PLoS Genetics | www.plosgenetics.org 10 February 2012 | Volume 8 | Issue 2 | e1002505T
a
b
l
e
4
.
S
u
m
m
a
r
y
o
f
c
i
s
e
Q
T
L
r
e
s
u
l
t
s
f
o
r
s
e
l
e
c
t
e
d
e
x
p
r
e
s
s
i
o
n
p
r
o
b
e
s
s
i
g
n
i
f
i
c
a
n
t
l
y
a
s
s
o
c
i
a
t
e
d
w
i
t
h
M
e
t
S
a
n
d
s
h
o
w
i
n
g
d
i
f
f
e
r
e
n
t
i
a
l
A
B
D
-
G
L
U
e
x
p
r
e
s
s
i
o
n
i
n
M
o
l
O
B
B
n
e
t
w
o
r
k
a
n
d
s
i
n
g
l
e
-
g
e
n
e
a
s
s
o
c
i
a
t
i
o
n
a
n
a
l
y
s
e
s
(
F
D
R
P
,
0
.
0
1
)
.
D
e
p
o
t
H
G
N
C
A
n
a
l
y
s
i
s
a
p
p
r
o
a
c
h
M
o
d
u
l
e
D
E
-
M
e
t
S
P
v
a
l
u
e
D
E
A
B
D
-
G
L
U
P
v
a
l
u
e
M
M
P
v
a
l
u
e
S
N
P
e
Q
T
L
P
v
a
l
u
e
S
N
P
-
B
M
I
P
v
a
l
u
e
*
S
N
P
-
W
H
R
-
B
M
I
a
d
j
P
v
a
l
u
e
*
S
N
P
-
H
D
L
P
v
a
l
u
e
*
*
S
N
P
-
T
G
P
v
a
l
u
e
*
*
A
B
D
A
K
A
P
1
1
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
p
u
r
p
l
e
5
.
3
E
-
0
4
1
.
0
E
-
0
5
7
.
3
E
-
1
4
r
s
2
0
4
4
7
3
2
7
.
8
E
-
0
6
0
.
5
9
0
.
2
2
4
.
3
E
-
0
3
0
.
5
2
A
B
D
H
L
A
-
D
P
B
1
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
b
l
u
e
9
.
6
E
-
0
4
1
.
3
E
-
0
4
3
.
6
E
-
0
9
r
s
2
0
6
4
4
7
8
3
.
3
E
-
0
8
0
.
3
8
0
.
8
0
0
.
4
8
0
.
4
3
A
B
D
E
F
C
A
B
8
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
b
l
a
c
k
2
.
0
E
-
0
5
2
.
1
E
-
0
4
3
.
3
E
-
0
9
r
s
6
5
7
9
0
3
8
1
.
1
E
-
0
5
0
.
8
9
0
.
2
7
0
.
3
3
0
.
3
8
A
B
D
G
A
L
N
T
L
1
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
c
y
a
n
9
.
1
E
-
0
8
1
.
6
E
-
0
4
5
.
2
E
-
0
9
r
s
1
4
6
6
2
5
5
8
.
8
E
-
0
6
0
.
1
5
0
.
1
5
0
.
3
3
0
.
1
8
A
B
D
N
U
A
K
1
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
b
l
a
c
k
8
.
0
E
-
0
7
1
.
3
E
-
0
4
3
.
8
E
-
0
4
r
s
1
0
7
7
8
4
5
6
2
.
1
E
-
0
5
0
.
9
9
0
.
1
5
0
.
5
3
0
.
4
0
A
B
D
A
T
P
8
B
4
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
b
l
a
c
k
7
.
8
E
-
0
5
3
.
4
E
-
0
7
2
.
0
E
-
0
9
r
s
1
0
5
1
9
2
4
6
3
.
2
E
-
0
6
0
.
1
6
0
.
4
2
0
.
5
6
0
.
1
1
G
L
U
A
T
P
8
B
4
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
r
o
y
a
l
b
l
u
e
3
.
2
E
-
0
4
3
.
4
E
-
0
7
9
.
3
E
-
1
1
r
s
7
4
9
5
0
5
7
3
.
3
E
-
0
5
0
.
3
3
0
.
6
8
0
.
7
7
0
.
6
6
G
L
U
L
T
B
P
2
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
A
B
D
_
G
L
U
D
E
t
u
r
q
u
o
i
s
e
5
.
3
E
-
0
5
3
.
0
E
-
0
8
4
.
5
E
-
0
9
r
s
2
1
0
9
7
5
0
1
.
4
E
-
0
4
0
.
0
9
0
.
7
5
0
.
4
8
0
.
1
4
A
B
D
P
H
O
S
P
H
O
2
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
e
Q
T
L
o
v
e
r
l
a
p
b
l
u
e
2
.
8
E
-
0
4
0
.
1
1
3
.
4
E
-
0
3
r
s
8
2
0
7
5
.
9
E
-
2
0
0
.
1
7
0
.
3
0
0
.
2
7
0
.
8
1
G
L
U
P
H
O
S
P
H
O
2
s
i
n
g
l
e
-
g
e
n
e
:
M
e
t
S
&
e
Q
T
L
o
v
e
r
l
a
p
t
u
r
q
u
o
i
s
e
1
.
5
E
-
0
4
0
.
1
1
0
.
0
2
r
s
8
2
0
7
3
.
1
E
-
0
8
0
.
1
7
0
.
3
0
0
.
2
7
0
.
8
1
A
B
D
N
B
N
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
9
.
3
E
-
0
4
0
.
1
5
3
.
6
E
-
0
5
r
s
2
7
3
5
3
8
5
6
.
9
E
-
1
2
0
.
3
0
N
A
0
.
9
8
0
.
7
9
A
B
D
P
G
M
1
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
6
.
6
E
-
0
5
9
.
7
E
-
0
3
2
.
6
E
-
1
3
r
s
2
2
6
9
2
6
0
1
.
6
E
-
0
6
0
.
3
3
N
A
0
.
4
2
0
.
9
9
A
B
D
R
A
R
R
E
S
2
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
1
.
9
E
-
0
5
0
.
3
8
8
.
9
E
-
1
5
r
s
1
0
2
8
2
4
5
8
1
.
5
E
-
1
0
6
.
0
E
-
0
4
0
.
2
8
0
.
4
7
0
.
5
2
A
B
D
R
P
P
1
4
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
8
.
2
E
-
0
4
0
.
4
3
4
.
8
E
-
0
7
r
s
3
7
7
3
0
1
0
2
.
3
E
-
1
3
0
.
8
3
N
A
0
.
8
5
0
.
5
9
A
B
D
M
A
N
2
B
2
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
4
.
7
E
-
0
4
8
.
2
E
-
0
3
2
.
7
E
-
0
8
r
s
6
8
1
5
7
4
6
5
.
3
E
-
0
9
0
.
7
9
N
A
0
.
3
5
0
.
7
6
A
B
D
S
E
N
P
3
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
8
.
1
E
-
0
4
0
.
3
1
2
.
1
E
-
0
6
r
s
8
0
7
3
4
9
8
5
.
2
E
-
0
6
0
.
4
0
N
A
0
.
3
7
0
.
4
6
A
B
D
A
N
A
P
C
4
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
6
.
4
E
-
0
4
0
.
8
6
3
.
9
E
-
0
8
r
s
1
1
9
3
7
7
4
2
1
.
8
E
-
0
5
0
.
0
2
N
A
0
.
1
4
0
.
1
7
A
B
D
C
1
4
o
r
f
1
2
9
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
1
.
8
E
-
0
4
8
.
5
E
-
0
3
5
.
8
E
-
0
7
r
s
4
9
0
5
4
8
0
1
.
5
E
-
1
9
0
.
8
6
N
A
0
.
0
9
0
.
7
9
A
B
D
S
Y
T
L
2
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
1
.
7
E
-
0
4
0
.
1
2
2
.
7
E
-
0
6
r
s
5
8
0
4
5
9
4
.
9
E
-
0
5
0
.
7
7
N
A
0
.
8
0
0
.
0
4
A
B
D
E
X
D
2
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
4
.
2
E
-
0
4
0
.
5
2
5
.
4
E
-
0
9
r
s
7
6
1
8
9
9
2
.
9
E
-
0
5
0
.
0
2
N
A
0
.
4
7
0
.
8
3
A
B
D
T
O
M
M
2
2
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
4
.
2
E
-
0
4
0
.
8
6
5
.
4
E
-
0
8
r
s
1
2
0
0
4
9
.
5
E
-
0
6
0
.
4
8
N
A
0
.
4
6
0
.
2
4
A
B
D
C
O
L
2
1
A
1
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
4
.
6
E
-
0
4
0
.
5
8
2
.
0
E
-
0
4
r
s
1
9
2
5
1
6
6
2
.
9
E
-
0
5
0
.
1
9
N
A
0
.
5
9
0
.
2
4
A
B
D
O
S
B
P
L
1
A
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
4
.
9
E
-
0
5
0
.
2
7
3
.
0
E
-
1
6
r
s
2
2
7
8
6
6
4
6
.
0
E
-
0
6
0
.
4
4
N
A
0
.
9
0
0
.
9
0
A
B
D
H
I
G
D
2
A
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
5
.
7
E
-
0
4
0
.
5
5
7
.
3
E
-
1
3
r
s
1
0
6
5
2
1
2
9
.
7
E
-
0
8
0
.
7
7
N
A
0
.
0
8
0
.
8
9
A
B
D
e
i
g
e
n
g
e
n
e
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
b
r
o
w
n
N
A
N
A
N
A
r
s
2
8
3
5
6
3
0
1
.
4
E
-
0
7
0
.
1
5
N
A
0
.
0
8
0
.
0
2
G
L
U
I
F
N
A
R
1
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
d
a
r
k
g
r
e
e
n
2
.
1
E
-
0
4
0
.
4
7
4
.
4
E
-
0
4
r
s
2
8
3
4
1
8
8
2
.
8
E
-
0
6
0
.
9
0
N
A
0
.
7
0
0
.
6
1
G
L
U
E
P
D
R
1
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
d
a
r
k
g
r
e
e
n
1
.
5
E
-
0
4
0
.
0
4
1
.
7
E
-
1
1
r
s
1
6
6
8
3
5
7
6
.
4
E
-
0
5
0
.
0
6
N
A
0
.
5
6
0
.
3
8
G
L
U
e
i
g
e
n
g
e
n
e
s
i
n
g
l
e
t
i
s
s
u
e
n
e
t
w
o
r
k
d
a
r
k
g
r
e
e
n
N
A
N
A
N
A
r
s
9
0
9
9
8
2
8
.
3
E
-
0
8
0
.
5
8
N
A
0
.
6
7
0
.
5
1
A
B
D
K
L
H
L
2
9
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
0
.
0
2
5
.
1
E
-
0
8
1
.
2
E
-
0
3
r
s
2
5
7
7
7
5
6
7
.
4
E
-
0
7
0
.
5
5
0
.
7
9
0
.
5
3
0
.
6
0
A
B
D
H
L
A
-
D
P
A
1
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
0
.
0
2
4
.
5
E
-
0
5
1
.
1
E
-
0
7
r
s
3
0
7
7
3
.
1
E
-
0
5
0
.
2
8
0
.
2
0
0
.
3
6
0
.
3
3
A
B
D
H
L
A
-
D
R
B
1
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
1
.
4
E
-
0
3
2
.
2
E
-
0
4
1
.
2
E
-
0
6
r
s
2
3
9
5
1
8
5
1
.
6
E
-
0
6
0
.
1
1
2
.
4
E
-
0
4
8
.
7
E
-
0
4
0
.
4
0
A
B
D
G
A
L
N
T
L
1
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
9
.
1
E
-
0
8
1
.
6
E
-
0
4
6
.
3
E
-
0
9
r
s
1
4
6
6
2
5
5
8
.
8
E
-
0
6
0
.
2
1
0
.
1
5
0
.
3
3
0
.
1
8
G
L
U
H
L
A
-
D
R
B
1
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
0
.
1
2
2
.
2
E
-
0
4
1
.
5
E
-
0
5
r
s
6
6
0
8
9
5
3
.
4
E
-
0
5
0
.
2
3
3
.
5
E
-
0
3
0
.
0
3
0
.
9
6
G
L
U
H
L
A
-
D
R
B
1
c
o
n
s
e
n
s
u
s
-
n
e
t
w
o
r
k
y
e
l
l
o
w
0
.
1
2
2
.
2
E
-
0
4
1
.
5
E
-
0
5
r
s
2
3
9
5
1
8
5
7
.
3
E
-
0
5
0
.
1
1
2
.
4
E
-
0
4
8
.
7
E
-
0
4
0
.
4
0
Adipose eSNPs Associated with Metabolic Syndrome
PLoS Genetics | www.plosgenetics.org 11 February 2012 | Volume 8 | Issue 2 | e1002505multiple testing correction (FDR P,0.05), we found the 21q22.13
locus (rs2835630, p=1.4*10
27, FDR P=0.04) significantly
associated with the ABD brown module eigengene and the 6p21
locus (rs909982, p=8.3*10
28, FDR P=0.02) associated with the
GLU darkgreen module. The SNP at the 21q22.13 locus was
within the Down Syndrome Critical Region in a high LD region
containing the TTC3 and DSCR9 genes. Of the two genes, only
TTC3 was expressed in ABD. This gene was not differentially
expressed between MetS cases and controls (p=0.01, FDR
P=0.06) and assigned to the turquoise module (MM=20.62,
P=3.4*10
27). Remarkably, TTC3 is an E3 ligase facilitating
ubiquitination and degradation of phosphorylated Akt [38]
whereas Akt has a key role in metabolic regulation. The SNP at
the 6p21 locus was in the intronic region of LRFN2. This gene was
however not expressed in GLU and plays a role in neuronal
development. These loci may act as a master regulator of the genes
in the module mediating a gene expression regulatory mechanism.
Confirmation of associations between eSNPs and MetS–
related phenotypes in two large GWA cohorts
To validate our results, we tested our prioritised eSNPs for
association with MetS-related phenotypes using data from two
large GWA cohorts. Based on the eQTL analyses, we prioritised a
set of 32 eSNPs that were associated with MetS-associated
probesets/modules (Table 4): 15 eSNPs associated with probesets
in the most significant ABD (brown) module, three eSNPs in the
most significant GLU (darkgreen) module, and 14 eSNPs
associated with genes exhibiting inter-depot differences in the
consensus (yellow) module and/or with the single-gene models
(nine of which were also significantly associated with MetS). The
32 eSNPs were tested for association with individual phenotypic
components of MetS and the fourteen eSNPs exhibiting ABD-
GLU inter-depot differences were tested for association with
WHR-adjBMI (Table 4): Association with BMI and WHR-
adjBMI was assessed using data from the GIANT consortium
comprising ,120,000 individuals and with HDL and TG in
.100,000 individuals from a large-scale publicly available lipid
study [4]. For each of the four clinical phenotypes, a Bonferroni-
adjusted significance threshold of 1.6*10
23 was chosen such that
Pr(Number of False Positives .0) ,0.05 by correcting for 32 SNP-
clinical phenotype associations. This threshold was corresponding
to a FDR of 0.03 across 110 tests. Adopting a much simplified
scenario given the complex correlation structure of the MetS-
related traits, we found three significant associations which was
more than expected by chance; assuming independence between
the 110 tests, the binomial probability was 7.3*10
24. SNP
rs10282458, was significantly associated with gene expression
levels of the adipokine RARRES2 encoding chemerin, and was
significantly associated with BMI (genomic control corrected
p=6.0*10
24). RARRES2 gene expression levels showed a
familiality of 0.53 in the MolTWIN ABD dataset and were highly
connected with the brown module eigengene (MM=0.83). In
MolOBB, expression levels of RARRES2 were strongly associated
with MetS (p=1.9*10
25) and with the individual components of
MetS: waist (p=1.6*10
28), HDL (p=2.0*10
25) and diastolic
blood pressure (p=1.5*10
24). SNP rs2395185, which affected
expression levels of HLA-DRB1, was significantly associated with
HDL (genomic-control corrected p=8.7*10
24). Expression levels
of HLA-DRB1 showed a familiality of 0.59 in MolTWIN ABD and
were correlated with waist circumference (p=2.9*10
25) and HDL
(p=5.3*10
25) in MolOBB.
Next, we tested the 14 eSNPs that were associated with ABD-
GLU inter-depot differences and rs10282458 for association with
WHR-adjBMI in the GIANT consortium. By focusing on WHR
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PLoS Genetics | www.plosgenetics.org 12 February 2012 | Volume 8 | Issue 2 | e1002505after adjustment for BMI, we anticipated to detect associations
with body fat distribution independent of those influencing overall
adiposity. SNP rs10282458 was indeed associated with BMI but
not with WHR-adjBMI (Table 4). We found one significant
association (genomic-control corrected) between eSNP rs2395185,
influencing HLA-DRB1 expression levels in ABD and GLU, and
WHR-adjBMI (p=2.4*10
24). These results may suggest that
differential regulation of the HLA-DRB1 region is associated with
WHR-adjBMI.
Discussion
Given that many molecular processes in multiple tissues could
be involved in the onset of MetS, we genotyped and profiled gene
expression in WB and two different adipose depots, ABD and
GLU, from 73 individuals. After constructing coexpression
networks for each tissue independently and between tissues, we
identified MetS-associated modules of coexpressed genes enriched
for immune response and oxidative phosphorylation pathways in
adipose depots but not in WB. By testing eSNPs, that were
associated with expression of the genes in the MetS-associated
modules, for association with MetS-related phenotypes in large
scale GWA datasets, we found associations with RARRES2 and
HLA-DRB1. Thus, by constructing networks across and within
different adipose depots combined with single-gene analysis, two
signals which had not reached genome-wide significance in GWA
datasets of more than 100,000 individuals were identified.
Adipose tissue is a dynamic endocrine organ that secretes
proteins such as cytokines and hormones, collectively named
adipokines. Adipokines may regulate energy and vascular
homeostasis, as well as inflammatory processes, and are involved
in glucose and lipid metabolism. Chemerin, encoded by
RARRES2, is an adipokine known to play an important role in
adipogenesis and metabolic homeostasis and modulating chemo-
taxis and activation of dendritic cells and macrophages [39,40]. In
humans, chemerin levels are associated with multiple components
of MetS including BMI, plasma TG, hypertension, and HDL [41–
43]. In a study of Caucasian individuals, a serum chemerin
concentration of 240 ug/L was selected to diagnose MetS with a
sensitivity of 75% and specificity of 67% [44]. Chemerin
expression and secretion from adipose tissue increases with
adipocyte differentiation and obesity [39,41]. Despite the evidence
linking circulating chemerin levels with metabolic phenotypes, to
our knowledge, this is the first study that identified loci near genes
encoding chemerin for MetS-related phenotypes. A GWA study
reported that serum chemerin levels were heritable and found a
genetic association between the EIDL3 gene and serum chemerin
levels supporting a potential role for chemerin in angiogenesis
[45]. Given the convergence of adipocyte and macrophage
function, chemerin may provide an interesting link between
chronic inflammation, often associated with obesity-related
diseases, and obesity and metabolic function in human adipose
tissue with MetS.
In humans, variations in adipose tissue distribution is associated
to different metabolic consequences, with abdominal increase of
fat producing a much greater risk for metabolic traits than
gluteofemoral fat, suggesting differential regulation between the
two adipose depots [20]. We identified a MetS-associated module
highly preserved across the two adipose depots and enriched for
immune response pathways, with 15% of the probesets differen-
tially expressed between tissues. A modest association between
eSNP rs2395185, influencing HLA-DRB1 expression levels in ABD
and GLU, and WHR-adjBMI was found. The HLA-associated
SNP found in our study has also been linked to ulcerative colitis
[46,47]. Cis eQTLs of the HLA-DRB1 locus with other SNPs have
previously been associated with Type 1 diabetes in liver tissue [9]
and with cholesterol levels in omental and subcutaneous fat [4]
suggesting differential regulation of this locus across different
tissues.
The specific identified genetic associations were found with a
network approach rather than with single-gene association
between expression and clinical traits, even though there was
substantial concordance in results between the two strategies.
Investigating coexpression networks may be a more powerful
approach than a single-gene association analysis since most
cellular components are connected to each other through
regulatory, metabolic and protein-protein interactions and sum-
marising coexpressed genes in a single eigengene reduces the
number of tests significantly. In our study, we tested a set of SNPs,
associated with expression of genes in MetS-associated expression
modules in relevant tissues, with the hypothesis that these eSNPs
are enriched for SNP-MetS associations. Testing this small SNP
set for disease association in large GWAS cohorts revealed two
SNP-disease associations, the signals of which would have been
relatively weak in a genome-wide multiple-testing context.
An additional motivation for utilising a network-based approach
is that it is unlikely that MetS is a consequence of an abnormality
in a single gene product, but reflects the perturbations of a
particular functional module in the gene network by a complex
interaction of genetic and environmental interactions [48,49]. The
existence of distinct disease-specific functional modules is consis-
tent with: findings from GWA studies observing that many genetic
loci identified with GWAs for traits such as height, lipids and BMI
may be not randomly distributed with respect to biological
function [50], genes associated with similar disorders show higher
expression profiling similarity for their transcripts, and proteins
involved in the same disease have an increased tendency to
interact with each other [51].
We found an enrichment of oxidative phosphorylation genes in
the most significant ABD gene network module, which is
consistent with previous studies showing compelling evidence for
mitochondrial dysfunction in association with insulin resistance
and obesity [52,53]. Reduced mitochondrial biogenesis has been
demonstrated in humans with MetS, coinciding with reduced ATP
level and dysfunctional mitochondrial electron transport [54,55].
Mitochondrial dysfunction may lead to an increased production of
Reactive Oxygen Species and consequently oxidative stress which
is coupled to activation of inflammatory pathways and insulin
resistance in adipocytes [36,56].
The network topology-based approach helps to uncover
potential mechanisms that contribute to the shared pathophysiol-
ogy of the multiple components of MetS. Defects in gene products
that are part of the same pathway, may also affect other cellular
functions, resulting in potential comorbidity effects. Consistent
with this view, our results and those of other studies support the
idea that the chronic low-grade inflammatory condition that is
associated with obesity plays a role in the etiology of MetS [36].
Specifically, cells of the innate immune system, particularly
macrophages, are crucially involved in adipose inflammation
and systemic metabolic abnormalities [36]. CD163, one of the
hubgenes found this study, encodes a monocyte/macrophage
specific receptor whose soluble form (sCD163) is elevated in T2D
and obesity [34].
It is however not clear whether obesity is the origin or whether
inflammation is proximal to metabolic dysfunction [36]; a chronic
excess of nutrients can trigger metabolic dysfunction and
inflammatory responses simultaneously leading to metabolic excess
which also leads to inflammatory responses.
Adipose eSNPs Associated with Metabolic Syndrome
PLoS Genetics | www.plosgenetics.org 13 February 2012 | Volume 8 | Issue 2 | e1002505In any expression study, many expression traits associated with
the disease will not necessarily be causative, but instead be mostly
reactive to disease. In addition, expression levels represent
measurements from a heterogeneous mixtures of cells. It is
important to distinguish the effect of genetic variation on gene
expression from other factors that are reactive to the disease or
confounding factors that also correlate with expression variability.
Both our single-gene and network-based results showed that the
expression probesets and modules filtered by association with
MetS had increasing familiality and heritability levels, which may
suggest an enrichment of genetically relevant signals.
Our results arose principally from the analysis of gene
expression in ABD and GLU adipose depots, and not WB. In
addition, the heritability of the genes associated with MetS in both
ABD and GLU was high in ABD tissue of the twins but not in WB.
Moreover, the proportion of variance that was explained by the
fact that the twins attended the hospital together (common visit
effect) was high in WB, indicating stronger short-term environ-
mental effects on WB than ABD expression levels. These
observations suggest that WB is not necessarily the tissue of
choice to detect eQTLs that are of direct relevance to MetS.
In conclusion, we performed an eQTL study in WB, ABD and
GLU and highlighted two genetic loci associated with MetS
mediated by gene expression variation. Considering many genes
and their interactions influence complex traits such as MetS, the
integrated analysis of genotype data and expression networks
across multiple tissues relevant to the clinical traits under study is
an efficient strategy to identify novel genetic associations, and may
offer better targets for drug development.
Methods
Ethics statement
The MolTWIN study was approved by St. Thomas’ Hospital
Research Ethics Committee (EC04/015 Twins UK). The
MolOBB study received ethical approval from Oxfordshire REC
C (08/H0606/107). All participants gave informed consent.
MolOBB data collection
The MolOBB study consists of 44 healthy controls (27 men, 17
women) and 29 cases with MetS (16 men, 13 women) between 39
and 56 years old that were collected from the Oxford Biobank as
part of the MolPAGE consortium [57]. Based upon the IDF
Criteria (www.idf.org), MetS was assigned as central obesity (waist
circumference (or BMI.30 kg/m
2) plus any two of the following
four factors: raised triglycerides, reduced HDL cholesterol, raised
blood pressure or raised fasting plasma glucose [16]. Control
subjects were selected to be discordant from the MetS cases
(Table 1). From these individuals, ABD and GLU adipose and WB
samples were taken. A total of 143 samples were obtained, with 71
subjects successfully donating both tissue types, and one individual
donating only GLU. Subcutaneous adipose tissue from the
abdominal wall is taken at the level of the umbilicus; subcutaneous
gluteal tissue is taken from the upper outer quadrant of the buttock
and WB samples were taken using EDTA and PAXgene tubes.
Gene expression data is available at ArrayExpress (E-TABM-54).
MolTWIN collection
A total of 154 twins (56 monozygotic (MZ) pairs and 21
dizygotic (DZ) pairs), were ascertained from the UK Adult Twin
registry at St. Thomas’ Hospital [58] and recruited to participate
in this study. Gene expression data is available at ArrayExpress (E-
TABM-325). Eligible volunteers were healthy, Caucasian, post-
menopausal females of Northern European descent, aged between
45–76 years old. Twins were checked for zygosity using a panel of
47 SNPs [59]. Each participant donated subcutaneous adipose
tissue from the abdominal wall and WB; 34 MZ twin pairs
donated samples during two visits whereas 21 DZ pairs and 22
MZ pairs donated samples during one visit. Both twins in a pair
visited on the same day.
Gene expression profiling
For the WB samples, PAXgene tubes were used and RNA was
extracted according to the manufacturer’s protocol (PAXgene,
QIAGEN). Total RNA was extracted with TRIreagent (SIGMA-
ALDRICH, Gillingham, UK) from the fat biopsies and quantified
using a NanoDrop. For six of the MolOBB subjects and 30 of the
MolTWIN subjects from the first visit (15 MZ pairs), RNA was
split into two aliquots before labelling (technical replicates). RNA
was labelled using the MessageAmp II 96-well amplification kit
(Applied Biosystems, CA, USA). Labelled RNA was hybridized
onto Affymetrix hgu133plus2 arrays washed, stained, and scanned
for fluorescence intensity according to manufacturers protocols
(Affymetrix, Inc., USA). For each tissue, RNA samples were
randomised and extracted in batches of 12 samples, rerandomised
before labelling in 96-well plates and hybridised in batches of 12
samples on a plate-row by plate-row basis. Quality control checks
involved signal intensities, background intensity, expression of
control genes and spike-ins, as well as a spatial representation of
the intensities. To identify outliers further, principal components
analysis was performed on the normalised gene expression dataset
using the NIPALS algorithm. The majority of the probes on the
hgu133plus2 arrays were collected into 17,726 non-overlapping
probesets according to Entrez Gene annotations provided by Dai
et al. [60].
Gene expression preprocessing
After outlying arrays had been removed, there remained data in
the MolOBB study from 54 ABD samples (four in technical
duplicate), 65 GLU samples (five in technical duplicate) and 68
WB samples. During 202 visits, 231 MolTWIN samples from ABD
(29 technical replicates) were successfully profiled from 145
individuals. From the WB samples, 217 MolTWIN gene
expression profiles for 141 individuals were generated during
191 visits (26 technical replicates). All arrays were normalised
concurrently across datasets for comparisons between tissues and
separately for comparisons within a single tissue using GC robust
multi-array analysis [61]. Gene-specific expression summaries
were averaged across technical replicates of a sample. We then
filtered the data, retaining only those probesets that were
annotated to an autosomal location, and also showed a mean
intensity above 4 arbitrary units of log2 (intensity) in at least 10%
of individuals. After this filtering stage in the MolOBB, there
remained 8619 probesets in the ABD-GLU dataset, 8941 in the
ABD dataset, 8307 in the GLU and 6909 probesets in the WB
dataset. In the MolTWIN study, 8928 probesets in the ABD
dataset and 9071 probesets in the WB dataset remained.
Genotyping and quality control
DNA was successfully extracted from WB samples using
GeneCatcher (Invitrogen Life Technologies, Carlsbad, USA)
according to manufacturer’s protocol. 166 samples (70 MolOBB,
96 twins (one MZ individual per MZ pair and two DZ
individuals per DZ pair)) are genotyped with Illumina 317K
BeadChip SNP arrays (Illumina, San Diego, USA). Genotype data
(EGAS00000000102) is available at EGA.
Quality control on the genotyped subjects was performed
applying slightly changed quality control filters as described
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Two twin samples are removed due to sample success rate ,95%
and three samples (two twins, one MolOBB) were removed due to
non European ancestry. SNPs are removed when minor allele
frequency (MAF) ,1% or showed a success rate ,95% and
MAF.5%, and when ,99% and MAF,5%. Hardy-Weinberg
equilibrium was calculated by combining all unrelateds of the
MolOBB and MolTWIN dataset (e.g.one twin per twinpair) and
SNPs were removed if P value,10
24. After QC, genotypes of the
ungenotyped MZ twin were copied from genotyped MZ twin.
Finally, we included 69 MolOBB individuals and 144 twins
genotyped for 296,017 autosomal SNPs.
Statistical analysis
Identifying differentially expressed genes. For the
differential expression analysis between MetS cases and controls,
we investigated the effect of gender, RNA Integrity Number, age
and plate on gene expression measurements. Several probesets
were associated with gender and plate but none with age or RNA
Integrity Number. We then tested all detected probesets for
association with MetS adjusting for gender and plate-effects using
linear models. To investigate whether genes are differentially
expressed between ABD and GLU, we used a linear mixed model
on in which tissue (ABD versus GLU), MetS case-control status,
gender, and plate were fitted as fixed effects, and subject (sample
donor) as a random effect. Models were fitted using the Rpackage
Maanova [63]. The pvalues from the Fs test were corrected for
multiple testing using FDR [30] and probesets were considered
significant if the adjusted p-value of the Fs test was ,0.01.
Construction of the weighted gene coexpression
networks. WeusedtheRpackageWGCNAfornetworkconstru-
ction. To construct single tissue and consensus eigengene networks,
we adjusted the tutorials from the WGCNA website (http://www.
genetics.ucla.edu/labs/horvath/CoexpressionNetwork/Rpackages/
WGCNA/Tutorials/index.html). A weighted gene co-expression
network reconstruction algorithm was used to reconstruct co-
expression networks for each of the three MolOBB datasets
(ABD, GLU and WB) [64]. Briefly, a Pearson correlation matrix
(gene-by-gene matrix) between all gene expression pairs was
constructed. To define the weighted coexpression network, an
adjacency matrix was constructed using a soft power adjacency
function aij~cor xi,xj
   b. This parameter b of the power
function was defined in such a way that the resulting co-
expression network (adjacency matrix) satifies approximate scale-
free topology. To measure how well the network satisfied a
scale-free topology, we used fitting index R2 of the linear model
that regressed log(p(k)) on log(k) where k is connectivity and
p(k) is the frequency distribution of connectivity [64]. The fitting
index of a perfect scale-free network is 1. For the MolOBB ABD,
GLU and WB datasets, we chose a power of 5, 6 and 12,
respectively, which resulted to an approximate scale-free topology
network with the scale-free fitting index R2 greater than 0.8. The
distribution p(k) of the resulting network approximated a power
law: p(k)*k{1:29 [64].
Modules were defined as groups of genes with similar patterns of
connection strengths with all other genes of the network. The
adjacency matrix was transformed into a topological overlap
matrix. To identify modules of highly co-regulated genes, we used
average linkage hierarchical clustering to group genes based on the
topological overlap of their connectivity, followed by a dynamic
cut-tree algorithm to cluster dendrogram branches into gene
modules [65].
To summarise the gene expression profiles of an entire module
by a single gene expression profile, module eigengenes were
computed. Gene expression profiles for each module were
decomposed using singular value decomposition (X~UDVT),
where X is a n-by-g matrix where g is the number of genes and n
the number of samples. The first column of V represented the
module eigengene. These module eigengenes were tested for
association with the MetS-related phenotypes adjusted for plate
and gender using a linear regression model. These associations
were adjusted for multiple testing by applying a 1% FDR [30].
To determine whether the MetS-associated modules are
biologically meaningful, GO enrichment analyses were conducted
using DAVID [66]. For each of the MetS-associated modules, we
examined enrichment of Biological Process GO terms as
compared to the expressed probesets of that tissue using a Fisher’s
exact test. FDR Pvalues,0.01 were considered significant [30].
Whole network connectivities were defined as the sum of
connection strength with the other network genes. The intramod-
ular connectivity (kme) of the i
th gene is defined as the absolute
value of the correlation between the i
th expression profile and the
module eigengene (ME): kme(i)~ cor(x(i),ME) jj . Modules were
visualised using the program VisANT [67].
To assess the preservation of network properties across the ABD
and GLU datasets, we applied differential eigengene network
analysis to identify consensus modules [29]. These consensus
modules were defined using consensus dissimilarity and used for
hierarchical clustering. To compare the consensus eigengene
networks of ABD and GLU whose adjacency matrices are A1
eigen
and A2
eigen we used a preservation network Preserv(A1
eigen,A2
eigen)
in which adjacencies are defined as Preserv
(1,2)
ij ~1{
cor(E1
i ,E1
j ){cor(E2
i ,E2
j )
  
  
2
. Here, E1
i and E2
i denote the eigen-
genes of the I
th consensus module in ABD and GLU, respectively.
High levels of the preservation network indicate a strong
preservation between I and J across the two networks. The density
D is an aggregate measure of adjacency preservation between the
A(1) and A(2) [29].
Variability analysis. Maximum likelihood estimation of
variance components from the MolTWIN dataset was
performed by fitting a linear mixed-effects model using the lme4
package [68]. For each normalised probeset or module eigengene,
Yijkl, we fitted a model for the l
th aliquot (1,2) from a biological
sample taken at the k
th visit (1,2) of the j
th twin (1,2) from the i
th
pair (1,2,..,76):
Yijkl~mzpzPijzZij ðÞ zEijzWikzVijkzeijkl
with m the overall mean and p the batch-effect i.e. modelling
variation across 96-well plates (fixed effects). The random effects
Pij, Zij, Eij, Wik, Vijk, eijkl represent pair (common to a pair of
twins, irrespective of zygosity), zygosity indicator (shared by a pair
of MZ twins (Zi) but not by a pair of DZ twins (Zij)), individual
environmental, common visit, individual visit and residual
experimental error effects, respectively. The total phenotypic
variance s2
T can be decomposed into the variances of P, Z, E, W,
V and, e respectively: s2
T~s2
Pzs2
Z zs2
Ezs2
W zs2
V zs2
e.
To estimate the familiality (genetic and common environmental
components) among twin pairs, we calculated: F2~(s2
Pzs2
Z)=s2
T.
where s2
P represents the genetic and common-environmental
phenotypic covariance between a pair of DZ twins, irrespective of
zygosity. DZ pairs share half their additive genetic variance plus all
of their common environmental variance. MZ pairs share this
variance, but in addition also share the remaining half of additive
genetic variance. The latter extra covariance is parameterized by
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Z. The heritability was estimated by 2
s2
Z
s2
T
. Differences between
the familiality distributions in MolTWIN ABD and WB were
determined using the Wilcoxon Signed Rank Test. Familiality
differences between the MetS-associated probesets or module
eigengene and the probesets or module eigengenes that were not
associated with MetS were calculated using the Wilcoxon Rank
Sum Test.
eQTL analysis. We selected subjects who had complete data
on plate, gender, casecontrol status, gene expression and
genotypes. We set out to identify SNPs that affect gene
expression levels in cis. We defined an association between a
SNP and gene expression level as cis-acting if the SNP was located
within 500 kb from the start or stop position of the annotated gene
(NCBI build 36). Genotypes were coded as 0, 1, and 2
corresponding to the counts of the minor allele and an additive
model was fitted in all models. For each of the genes, each SNP in
the cis region was tested independently.
In the MolOBB study, SNP associations were calculated by
regressing expression level against using a linear regression model
adjusting for gender and plate-effects. In the MolTWIN study, we
fitted linear mixed models, for which twin pairing, zygosity,
individual visit, common visit, individual environment and
residual effect were fitted as random effects and genotype and
plate as fixed effects. eQTL associations in MolOBB and
MolTWIN were calculated with the Rpackages lm and lme4,
respectively. In the ABD meta-analysis, we combined study-
specific allelic effect-estimates on 8242 probesets expressed in both
ABD MolOBB (N=52) and MolTWIN (N=137) using a fixed
effect model, using the inverse of the variance of the study-specific
allelic effect-estimates to weight the contribution of the two studies
[37]. Results were checked for heterogeneity and adjusted for
multiple testing by FDR [30].
Follow-up of SNP–MetS associations in independent
cohorts. In order to followup eSNPs in independent cohort we
assembled a set of 32 eSNPsbased on two criteria: i. Expression levels
had to be differentially expressed between MetS cases and controls
a n ds h o w e dah i g hM M( p ,0.01) with the brown module in ABD or
the darkgreen module in GLU. ii. Expression levels in yellow
consensus module or gene-by-gene model had to be differentially
expressed between depots. In order to confirm the associations
between the 32 eSNPs and the MetS related phenotypes in
independent cohorts, we obtained results of relevant meta-analyses
conducted by two consortia. For the BMI associations, 32 eSNPs
were tested for association in the GIANT consortium consisting of
.120,000 individuals. To confirm associations with TG and HDL,
we used previously published GWA results comprising .100,000
individuals [4]. For the 14 eQTL associations affecting gene
expression levels associated with interdepot differences, 14 eSNPs
were examined for association with WHR-BMIadj. Meta-analysis
statistics were obtained using weighted z-statistics and corrected for
genomic control. Foreachoffourclinicalphenotypes,thesignificance
threshold 1.6*10
23 is chosen such that Pr(Number of False Positives
.0) ,0.05. Exact binomial probabilities were calculated through
repeated applications of the standard binomial formula.
We selected 29 variants and their proxies (r
2.0.5) previously
associated to MetS or a pair of MetS traits [32] and tested these for
association with expression levels in ABD and GLU. Expression
levels of genes within 500 kb around SNP were examined for
differential expression between MetS cases and controls.
URL
All code is available at http://www.well.ox.ac.uk/ggeu/
PLoSGenet_Minetal_MolPAGE/.
Supporting Information
Figure S1 Study design for the three strategies. Pink, green and
purple colors represent single-gene approach, single tissue
eigengene network analysis and differential eigengene network
analysis, respectively.
(TIF)
Figure S2 Heatmap plot of the topological overlap in the ABD
gene network of 1000 random selected genes. In the heatmap,
each row and column corresponds to a gene, light color displays
low topological overlap, and darker color displays higher
topological overlap. The gene dendogram and module assignment
are shown along the left and top. The cyan and brown modules
are clearly seen by the darker squares along the diagonal.
(TIF)
Figure S3 Scatterplot between MM (x-axis) and gene signifi-
cance (y-axis) for MetS and the six MetS components in the GLU
darkgreen module. Gene significance (y-axis) is defined as 2log10
pvalue of the probeset-clinical trait association for each gene in the
darkgreen module. The red indicated genes show genes with
evidence for a cis eQTL and their eSNPs are examined for
association with BMI.
(TIF)
Figure S4 Venn diagram of number of expressed genes in
MolOBB ABD and GLU.
(TIF)
Figure S5 Preservation of genes across fat depots. A. Scatterplot
of 8256 median expression levels for ABD versus GLU. B.
Scatterplot of whole-network connectivities for ABD versus GLU.
Each point corresponds to a gene expression level. Spearman
correlations and the corresponding p-values are displayed in the
title of each plot. The whole-network connectivity is strongly
preserved between ABD and GLU.
(TIF)
Figure S6 Differential eigengene network analysis acrossdifferent
depots. A, B Dendrograms of consensus module eigengenes in ABD
and GLU. C, F.The heatmap plots of eigengene adjacencies in each
eigengene network. Each row and column corresponds to one
eigengene (labeled by consensus module color). Within each
heatmap, red indicates high adjacency and green displays a low
adjacency as shown by the color legend. D. Barplot shows the
preservation of relationships of consensus eigengenes of the
consensus modules. D represents the overall preservation measure.
E. Adjacency heatmap for the pairwise preservation network of
ABD (rows) and GLU (columns). Red indicates the adjacency.
(TIF)
Figure S7 Preservation of genes across MolOBB and MolTWIN
study. A. Scatterplot of 8242 median expression levels for
MolOBB ABD versus MolTWIN ABD. B. Scatterplot of whole-
network connectivities for MolOBB ABD versus MolTWIN ABD.
C. Scatterplot of intramodular connectivities of genes in the brown
module for MolOBB ABD versus MolTWIN ABD. Each point
corresponds to a gene expression level. Spearman correlations and
the corresponding p-values are displayed in the title of each plot.
The whole-network connectivity and intramodular connectivities
of genes in the brown module are preserved between MolTWIN
and MolOBB.
(TIF)
Table S1 Genes differentially expressed between MetS cases and
controls in ABD (‘single gene analysis’).
(DOC)
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controls in GLU (‘single gene analysis’).
(DOC)
Table S3 Module membership and association with MetS and
BMI in the MolOBB ABD dataset of genes identified by Emilsson
et al. [11] as part of a macrophage-enriched metabolic network in
subcutaneous adipose tissue and associated with obesity-related
traits.
(DOC)
Table S4 Evaluation of GWA SNPs previously associated with
MetS.
(DOC)
Table S5 Hubgenes (genes with highest rank of module
membership) in the modules strongest associated with MetS in
the ABD and GLU single-tissue networks.
(DOC)
Table S6 Modules for which eigengenes were significantly
correlated (FDR p,0.01) with MetS in ABD (N=6) and GLU
(N=6). FDR corrected pvalues for the associations with MetS and
six quantitative metabolic traits are shown.
(DOC)
Table S7 Enrichment of Biological Processes GO terms in
yellow consensus modules.
(DOC)
Table S8 Hubgenes (genes with highest rank of module
membership) in the yellow consensus module in both the ABD
and GLU networks.
(DOC)
Table S9 Median familiality estimates, assessed in MolTWIN
ABD and WB, of four groups of MolOBB MetS-associated
probesets identified using the single-gene approach, compared
with probesets not associated with MetS.
(DOC)
Text S1 Members of GIANT consortium and members of
MolPAGE consortium.
(DOC)
Text S2 Variability of MetS-associated gene expression.
(DOC)
Acknowledgments
We would like to thank all participants of the MolOBB and MolTWIN
studies.
Author Contributions
Conceived and designed the experiments: KTZ CML FK MIM JF TDS
CCH MA. Performed the experiments: KA AP AB MT MJN JC. Analyzed
the data: JLM GN IH NWR RM QFW. Contributed reagents/materials/
analysis tools: MolPAGE Consortium, GIANT Consortium. Wrote the
paper: JLM. Planned statistical design: GN CCH KTZ. Wrote scripts for
data manipulation: FHP JB.
References
1. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al. (2008) Common
variants near MC4R are associated with fat mass, weight and risk of obesity. Nat
Genet 40: 768–775.
2. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. (2009) Six new loci
associated with body mass index highlight a neuronal influence on body weight
regulation. Nat Genet 41: 25–34.
3. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. (2010)
Association analyses of 249,796 individuals reveal 18 new loci associated with
body mass index. Nat Genet 42: 937–948.
4. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al.
(2010) Biological, clinical and population relevance of 95 loci for blood lipids.
Nature 466: 707–713.
5. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. (2009) Genome-
wide association study of blood pressure and hypertension. Nat Genet 41:
677–687.
6. Tabara Y, Kohara K, Kita Y, Hirawa N, Katsuya T, et al. (2010) Common
variants in the ATP2B1 gene are associated with susceptibility to hypertension:
the Japanese Millennium Genome Project. Hypertension 56: 973–980.
7. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009)
Finding the missing heritability of complex diseases. Nature 461: 747–753.
8. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. (2010) A
map of human genome variation from population-scale sequencing. Nature 467:
1061–1073.
9. Schadt EE, Molony C, Chudin E, Hao K, Yang X, et al. (2008) Mapping the
genetic architecture of gene expression in human liver. PLoS Biol 6: e107.
doi:10.1371/journal.pbio.0060107.
10. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, et al. (2007) Genetic
variants regulating ORMDL3 expression contribute to the risk of childhood
asthma. Nature 448: 470–473.
11. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. (2008)
Genetics of gene expression and its effect on disease. Nature 452: 423–428.
12. Nica AC, Montgomery SB, Dimas AS, Stranger BE, Beazley C, et al. (2010)
Candidate causal regulatory effects by integration of expression QTLs with
complex trait genetic associations. PLoS Genet 6: e1000895. doi:10.1371/
journal.pgen.1000895.
13. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, et al. (2010) Trait-
associated SNPs are more likely to be eQTLs: annotation to enhance discovery
from GWAS. PLoS Genet 6: e1000888. doi:10.1371/journal.pgen.1000888.
14. Zhong H, Beaulaurier J, Lum PY, Molony C, Yang X, et al. (2010) Liver and
adipose expression associated SNPs are enriched for association to type 2
diabetes. PLoS Genet 6: e1000932. doi:10.1371/journal.pgen.1000932.
15. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome
among US adults: findings from the third National Health and Nutrition
Examination Survey. JAMA 287: 356–359.
16. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new
worldwide definition. Lancet 366: 1059–1062.
17. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet
365: 1415–1428.
18. Lusis AJ, Attie AD, Reue K (2008) Metabolic syndrome: from epidemiology to
systems biology. Nat Rev Genet 9: 819–830.
19. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol
Rev 74: 761–811.
20. Manolopoulos KN, Karpe F, Frayn KN (2010) Gluteofemoral body fat as a
determinant of metabolic health. Int J Obes (Lond) 34: 949–959.
21. Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, et al. (2006) Evidence
for a role of developmental genes in the origin of obesity and body fat
distribution. Proc Natl Acad Sci U S A 103: 6676–6681.
22. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF (2002) Depot-
specific hormonal characteristics of subcutaneous and visceral adipose tissue and
their relation to the metabolic syndrome. Horm Metab Res 34: 616–621.
23. Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, et al. (2008) Fat
depot-related differences in gene expression, adiponectin secretion, and insulin
action and signalling in human adipocytes differentiated in vitro from precursor
stromal cells. Diabetologia 51: 155–164.
24. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, et al. (2010) Meta-
analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual
dimorphism in the genetic basis of fat distribution. Nat Genet 42: 949–960.
25. Zhang S, Liu X, Yu Y, Hong X, Christoffel KK, et al. (2009) Genetic and
environmental contributions to phenotypic components of metabolic syndrome:
a population-based twin study. Obesity (Silver Spring) 17: 1581–1587.
26. Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, et al. (2008)
Prevalence and heritability of the metabolic syndrome and its individual
components in a Dutch isolate: the Erasmus Rucphen Family study. J Med
Genet 45: 572–577.
27. Sung J, Lee K, Song YM (2009) Heritabilities of the metabolic syndrome
phenotypes and related factors in Korean twins. J Clin Endocrinol Metab 94:
4946–4952.
28. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009)
Potential etiologic and functional implications of genome-wide association loci
for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
29. Langfelder P, Horvath S (2007) Eigengene networks for studying the
relationships between co-expression modules. BMC Syst Biol 1: 54.
30. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical
and powerful approach to multiple testing. Journal of the Royal Statistical
Society Series_ B 57: 289–300.
31. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, et al. (2010) Genetic
variants influencing circulating lipid levels and risk of coronary artery disease.
Arterioscler Thromb Vasc Biol 30: 2264–2276.
Adipose eSNPs Associated with Metabolic Syndrome
PLoS Genetics | www.plosgenetics.org 17 February 2012 | Volume 8 | Issue 2 | e100250532. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, et al. (2011) A
bivariate genome-wide approach to metabolic syndrome: STAMPEED
consortium. Diabetes 60: 1329–1339.
33. Langfelder P, Horvath S (2008) WGCNA: an R package for weighted
correlation network analysis. BMC Bioinformatics 9: 559.
34. Sporrer D, Weber M, Wanninger J, Weigert J, Neumeier M, et al. (2009)
Adiponectin downregulates CD163 whose cellular and soluble forms are
elevated in obesity. Eur J Clin Invest 39: 671–679.
35. Apostolidou S, Abu-Amero S, O’Donoghue K, Frost J, Olafsdottir O, et al.
(2007) Elevated placental expression of the imprinted PHLDA2 gene is
associated with low birth weight. J Mol Med (Berl) 85: 379–387.
36. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:
860–867.
37. Magi R, Morris AP (2010) GWAMA: software for genome-wide association
meta-analysis. BMC Bioinformatics 11: 288.
38. Suizu F, Hiramuki Y, Okumura F, Matsuda M, Okumura AJ, et al. (2009) The
E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated
Akt. Dev Cell 17: 800–810.
39. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, et al.
(2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte
metabolism. J Biol Chem 282: 28175–28188.
40. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, et al. (2003)
Specific recruitment of antigen-presenting cells by chemerin, a novel processed
ligand from human inflammatory fluids. J Exp Med 198: 977–985.
41. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, et al. (2007) Chemerin
is a novel adipokine associated with obesity and metabolic syndrome.
Endocrinology 148: 4687–4694.
42. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, et al. (2009)
Chemerin is associated with metabolic syndrome phenotypes in a Mexican-
American population. J Clin Endocrinol Metab 94: 3085–3088.
43. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. (2010)
Systemic chemerin is related to inflammation rather than obesity in type 2
diabetes. Clin Endocrinol (Oxf) 72: 342–348.
44. Stejskal D, Karpisek M, Hanulova Z, Svestak M (2008) Chemerin is an
independent marker of the metabolic syndrome in a Caucasian population–a
pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:
217–221.
45. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, et al. (2010) Chemerin,
a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 95:
2476–2485.
46. Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, et al. (2009) A
genome-wide association study identifies three new susceptibility loci for
ulcerative colitis in the Japanese population. Nat Genet 41: 1325–1329.
47. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative
colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide
association study. Nat Genet 41: 216–220.
48. Barabasi AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-
based approach to human disease. Nat Rev Genet 12: 56–68.
49. Schadt EE (2009) Molecular networks as sensors and drivers of common human
diseases. Nature 461: 218–223.
50. Lango AH, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010)
Hundreds of variants clustered in genomic loci and biological pathways affect
human height. Nature 467: 832–838.
51. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human
disease network. Proc Natl Acad Sci U S A 104: 8685–8690.
52. Kim JA, Wei Y, Sowers JR (2008) Role of mitochondrial dysfunction in insulin
resistance. Circ Res 102: 401–414.
53. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes.
Science 307: 384–387.
54. Nisoli E, Clementi E, Carruba MO, Moncada S (2007) Defective mitochondrial
biogenesis: a hallmark of the high cardiovascular risk in the metabolic
syndrome? Circ Res 100: 795–806.
55. Ren J, Pulakat L, Whaley-Connell A, Sowers JR (2010) Mitochondrial
biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med
88: 993–1001.
56. Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal
role in multiple forms of insulin resistance. Nature 440: 944–948.
57. Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, et al. (2006) The
in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue
NEFA metabolism: the first use of the Oxford Biobank. Diabetologia 49:
158–168.
58. Spector TD, Williams FM (2006) The UK Adult Twin Registry (TwinsUK).
Twin Res Hum Genet 9: 899–906.
59. Hannelius U, Gherman L, Makela VV, Lindstedt A, Zucchelli M, et al. (2007)
Large-scale zygosity testing using single nucleotide polymorphisms. Twin Res
Hum Genet 10: 604–625.
60. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/
transcript definitions significantly alter the interpretation of GeneChip data.
Nucleic Acids Res 33: e175.
61. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F A Model
Based Background Adjustment for Oligonucleotide Expression Arrays.
62. The Wellcome Trust Case Control Consortium (2007) Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 447: 661–678.
63. Wu H, Kerr K, Cui X, Churchill GA (2002) MAANOVA: A software package
for the analysis of spotted cDNA Microarray Experiments. In: Parmigiani G,
Garett ES, eds. The analysis of gene expression data Springer-Verlag. pp
313–341.
64. Zhang B, Horvath S (2005) A general framework for weighted gene co-
expression network analysis. Stat Appl Genet Mol Biol 4: Article17.
65. Langfelder P, Zhang B, Horvath S (2008) Defining clusters from a hierarchical
cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24: 719–720.
66. Huang W, Sherman BT, Tan Q, Kir J, Liu D, et al. (2007) DAVID
Bioinformatics Resources: expanded annotation database and novel algorithms
to better extract biology from large gene lists. Nucleic Acids Res 35:
W169–W175.
67. Hu Z, Mellor J, Wu J, DeLisi C (2004) VisANT: an online visualization and
analysis tool for biological interaction data. BMC Bioinformatics 5: 17.
68. Bates D (2005) R News 5: 1. http://cran.r-project.org/doc/Rnews/
Rnews_2005-1.pdf.
Adipose eSNPs Associated with Metabolic Syndrome
PLoS Genetics | www.plosgenetics.org 18 February 2012 | Volume 8 | Issue 2 | e1002505